PLYMOUTH MEETING, Pa., Sept. 17, 2014 /PRNewswire/ -- VRN Veterinarian Recommended Nutriceuticals®, maker of premier clinically-proven nutriceuticals, has announced the launch of the Fatty Acid Target Score (FATS™) test exclusively for veterinarians.
"We are excited to bring the first fatty acid blood test of its kind to the veterinarian community," said VRN's Chief Medical Officer, Steve Mehler, DVM, DACVS. "It's critical for veterinarians to know the exact balance of pro-inflammatory and anti-inflammatory fatty acids in canines and felines. In our landmark studies both in healthy canines and canines with inflammatory conditions, we observed the average ratio of the pro-inflammatory omega-6 fatty acid arachodonic acid (ARA) and the anti-inflammatory omega-3 fatty acid, eicosapentaenoic acid (EPA) was over 50 to 1, which is a major contributor to the epidemic of inflammatory conditions we are seeing in canines."
Bill Harris, PhD, President and CEO of OmegaQuant Analytics, said, "We are thrilled to partner with VRN to provide, what is to my knowledge, the first fatty acid blood test for dogs and cats. We know the importance of humans consuming a therapeutic amount of omega-3s and achieving an 8 percent Omega-3 Index, but the cutting edge research VRN is conducting is now proving the importance of omega-3 fatty acids in canines. The normal blood levels of omega-3s in canines and felines are even lower than humans, so it is important for veterinarians to monitor the levels of their patients and supplement accordingly."
VRN launched their first nutriceutical, Canine Omega Benefits®, in Q2 2014 after completing two of the largest randomized, double-blinded, placebo-controlled canine nutriceutical clinical trials ever completed, with impressive results. Canine Omega Benefits was shown to be effective to help reduce the clinical signs associated with osteoarthritis and dermatitis in canines.
About VRN Veterinarian Recommended Nutriceuticals®
VRN partners with veterinarians to distribute their premier clinically-proven nutriceuticals which are only available through a veterinarian's recommendation. VRN is guided by a group of veterinarian investors, advisors, researchers and board members that help drive VRN's growth plans and oversee new product development.
About OmegaQuant®
OmegaQuant Analytics is a USA-based, CLIA certified specialty laboratory that provides high quality fatty acid analytical services both to researchers and to consumers seeking to monitor their personal fatty acid levels, specifically the Omega-3 Index and Trans Fat Index. They also provide a Mother's Milk DHA test for breastfeeding mothers who want to monitor the DHA and trans fat content of their milk. The goal of OmegaQuant Analytics is to advance the science and expand the use of fatty acids to improve health.
Contact: David Krieg[email protected]
SOURCE VRN Veterinarian Recommended Nutriceuticals
Advertisement
"We are excited to bring the first fatty acid blood test of its kind to the veterinarian community," said VRN's Chief Medical Officer, Steve Mehler, DVM, DACVS. "It's critical for veterinarians to know the exact balance of pro-inflammatory and anti-inflammatory fatty acids in canines and felines. In our landmark studies both in healthy canines and canines with inflammatory conditions, we observed the average ratio of the pro-inflammatory omega-6 fatty acid arachodonic acid (ARA) and the anti-inflammatory omega-3 fatty acid, eicosapentaenoic acid (EPA) was over 50 to 1, which is a major contributor to the epidemic of inflammatory conditions we are seeing in canines."
Advertisement
Bill Harris, PhD, President and CEO of OmegaQuant Analytics, said, "We are thrilled to partner with VRN to provide, what is to my knowledge, the first fatty acid blood test for dogs and cats. We know the importance of humans consuming a therapeutic amount of omega-3s and achieving an 8 percent Omega-3 Index, but the cutting edge research VRN is conducting is now proving the importance of omega-3 fatty acids in canines. The normal blood levels of omega-3s in canines and felines are even lower than humans, so it is important for veterinarians to monitor the levels of their patients and supplement accordingly."
VRN launched their first nutriceutical, Canine Omega Benefits®, in Q2 2014 after completing two of the largest randomized, double-blinded, placebo-controlled canine nutriceutical clinical trials ever completed, with impressive results. Canine Omega Benefits was shown to be effective to help reduce the clinical signs associated with osteoarthritis and dermatitis in canines.
About VRN Veterinarian Recommended Nutriceuticals®
VRN partners with veterinarians to distribute their premier clinically-proven nutriceuticals which are only available through a veterinarian's recommendation. VRN is guided by a group of veterinarian investors, advisors, researchers and board members that help drive VRN's growth plans and oversee new product development.
About OmegaQuant®
OmegaQuant Analytics is a USA-based, CLIA certified specialty laboratory that provides high quality fatty acid analytical services both to researchers and to consumers seeking to monitor their personal fatty acid levels, specifically the Omega-3 Index and Trans Fat Index. They also provide a Mother's Milk DHA test for breastfeeding mothers who want to monitor the DHA and trans fat content of their milk. The goal of OmegaQuant Analytics is to advance the science and expand the use of fatty acids to improve health.
Contact: David Krieg[email protected]
SOURCE VRN Veterinarian Recommended Nutriceuticals
